Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer

Basal-like breast cancer is an incurable disease with limited therapeutic options, mainly due to the frequent development of anti-cancer drug resistance. Therefore, identification of druggable targets to improve current therapies and overcome these resistances is a major goal. Targeting DNA repair m...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieto-Jimenez, Cristina, Alcaraz-Sanabria, Ana, Martinez-Canales, Sandra, Corrales-Sanchez, Veronica, Montero, Juan Carlos, Burgos, Miguel, Nuncia-Cantarero, Miriam, Pandiella, Atanasio, Galan-Moya, Eva M., Ocaña, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730833/
https://www.ncbi.nlm.nih.gov/pubmed/33261142
http://dx.doi.org/10.3390/ijms21239034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730833/
https://www.ncbi.nlm.nih.gov/pubmed/33261142
http://dx.doi.org/10.3390/ijms21239034

Ejemplares similares